Marshall DA - Search Results

1

How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey.

Marshall DA, Johnson FR, Kulin NA, Ozdemir S, Walsh JM, Marshall JK, Van Bebber S, Phillips KA. Marshall DA, et al. Among authors: marshall jk. Health Econ. 2009 Dec;18(12):1420-39. doi: 10.1002/hec.1437. Health Econ. 2009. PMID: 19191268 Free PMC article.

2

Measuring patient preferences for colorectal cancer screening using a choice-format survey.

Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA. Marshall DA, et al. Among authors: marshall jk. Value Health. 2007 Sep-Oct;10(5):415-30. doi: 10.1111/j.1524-4733.2007.00196.x. Value Health. 2007. PMID: 17888107 Free article.

3

How does cost matter in health-care discrete-choice experiments?

Johnson FR, Mohamed AF, Ozdemir S, Marshall DA, Phillips KA. Johnson FR, et al. Among authors: marshall da. Health Econ. 2011 Mar;20(3):323-30. doi: 10.1002/hec.1591. Health Econ. 2011. PMID: 20217834 Free PMC article.

4

An empirical comparison of methods for analyzing correlated data from a discrete choice survey to elicit patient preference for colorectal cancer screening.

Cheng J, Pullenayegum E, Marshall DA, Marshall JK, Thabane L. Cheng J, et al. Among authors: marshall jk, marshall da. BMC Med Res Methodol. 2012 Feb 20;12:15. doi: 10.1186/1471-2288-12-15. BMC Med Res Methodol. 2012. PMID: 22348526 Free PMC article.

5

A review of studies examining stated preferences for cancer screening.

Phillips KA, Van Bebber S, Marshall D, Walsh J, Thabane L. Phillips KA, et al. Prev Chronic Dis. 2006 Jul;3(3):A75. Epub 2006 Jun 15. Prev Chronic Dis. 2006. PMID: 16776876 Free PMC article.

6

Valuing personalized medicine: willingness to pay for genetic testing for colorectal cancer risk.

Van Bebber SL, Liang SY, Phillips KA, Marshall D, Walsh J, Kulin N. Van Bebber SL, et al. Per Med. 2007 Aug;4(3):341-350. doi: 10.2217/17410541.4.3.341. Per Med. 2007. PMID: 29788665

7

The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada.

Marshall DA, Willison DJ, Grootendorst P, LeLorier J, Maclure M, Kulin NA, Sheehy OE, Warren L, Sykora K, Rahme E. Marshall DA, et al. Health Policy. 2007 Nov;84(1):1-13. doi: 10.1016/j.healthpol.2007.04.010. Epub 2007 Jun 13. Health Policy. 2007. PMID: 17570558

8

Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses.

Ferrusi IL, Marshall DA, Kulin NA, Leighl NB, Phillips KA. Ferrusi IL, et al. Among authors: marshall da. Per Med. 2009 Mar;6(2):193-215. doi: 10.2217/17410541.6.2.193. Per Med. 2009. PMID: 20668661 Free PMC article.

9

Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample.

Knight SJ, Mohamed AF, Marshall DA, Ladabaum U, Phillips KA, Walsh JM. Knight SJ, et al. Among authors: marshall da. Med Decis Making. 2015 Aug 1;35(6):734-744. doi: 10.1177/0272989X14565820. Epub 2015 Jan 14. Med Decis Making. 2015. PMID: 25589525 Free PMC article.

10

Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine.

Marshall DA, Gonzalez JM, MacDonald KV, Johnson FR. Marshall DA, et al. Value Health. 2017 Jan;20(1):32-39. doi: 10.1016/j.jval.2016.08.737. Value Health. 2017. PMID: 28212966 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters